CNSP News and Press, CNS Pharmaceuticals Inc. From 03/12/21

The following slide deck was published by CNS Pharmaceuticals, Inc. in conjunction with this event. For further details see: CNS Pharmaceutical (CNSP) Investor Presentation - Slideshow

CNS Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire HOUSTON , March 4, 2021 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the de...

CNS Pharmaceuticals (CNSP) indicated that the clinical program for Berubicin is on track to start enrolling patients in March 2021.CNS' lead product candidate, Berubicin, is a novel anthracycline and the first anthracycline to cross the blood-brain barrier. It is in development for the t...

CNS Pharmaceuticals Berubicin Trial is On Schedule to Commence in March 2021 Potentially pivotal study evaluating efficacy of Berubicin in the treatment of adult Glioblastoma Multiforme (GBM), one of the most aggressive types of brain cancer PR Newswire HOUSTON ,...

WPD Pharmaceuticals (WPDPF) has signed an agreement with CNS Pharmaceuticals (CNSP) to obtain Investigational Medicinal Product ((IMP)) for use in the planned clinical trials of Berubicin.Berubicin is a novel anthracycline candidate for the treatment of a number of serious oncology ...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) ("WPD" or the “Company”) today announced that it has signed an agreement with CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS”) to obtain Investigational Medicina...

WPD and CNS Pharmaceuticals Announce Positive Opinion of the Polish Central Ethics Committee for the WPD-201 Study and Central IRB Study Level Approval for the CNS-201 Study WPD Pharmaceuticals plans to initiate a Berubicin Phase 2 adult GBM trial in the first half of 2021 and a...

ATA Creativity Global AACG -41% pared down yesterday's gain as Reddit users pump.Document Security Systems DSS -32% after pricing equity offering.Midatech Pharma (MTP) -21%.Twist Bioscience TWST -17% after JPMorgan downgrade.FirstMark Horizon Acquisition (FMAC) -...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The stock market tries to reset after its worst week since October with even popular stocks like Apple (NASDAQ:AAPL) and...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...